Pittsburgh biotech firm involved in development of potential COVID-19 treatment
CytoAgents, a Pittsburgh biotech firm, and Quotient Sciences, are accelerating development of a COVID-19 treatment. Read more >>
30
Apr
30
Apr
Local Gov’ts Get 90 Day Access to Regroup Mass Notification & CivicPlus
In response to the unprecedented COVID-19 pandemic, Regroup Mass Notification, a Nominated Competitor in the 2020 ‘ASTORS’ Homeland Security Awards Program, with its partner CivicPlus are offering cities and counties across the nation risk-free access to Regroup’s award-winning mass communication platform. Read more >>
30
Apr
Corbus Announces Publication of Lenabasum Systemic Sclerosis Double-Blind, Placebo-Control Phase 2 Clinical Trial Results in Arthritis & Rheumatology
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system (ECS), today announced the publication of results from the double-blind, randomized, placebo-controlled Phase 2 trial assessing the safety and efficacy of lenabasum in 42 patients with diffuse cutaneous systemic sclerosis in Arthritis & Rheumatology. Read more >>
30
Apr
Pittsburgh biotech firm involved in development of potential COVID-19 treatment
CytoAgents, a Pittsburgh biotech firm, and Quotient Sciences, are accelerating development of a COVID-19 treatment. The treatment would focus on what is called a “cytokine storm,” which is an excessive immune response that attacks the body. Read more >>
29
Apr
District Ventures Capital Invests in Premama Wellness
District Ventures Capital (“District Ventures”) announced today it has closed an equity investment with Premama Wellness (“Premama”), producers of a popular four-stage preconception through postnatal care supplement system based in Providence, Rhode Island. Read more >>
29
Apr
How some companies survive, even thrive, in viral crisis
When the coronavirus struck the United States hard last month, 22-year-old entrepreneur David Zamarin knew his company needed a Plan B — fast. As the economy essentially shut down, demand for his stain-resistant coatings was sure to drop. Read more >>
26
Apr
Free Online Practice SAT and ACT Test Sessions on Saturdays
Testive is offering proctored practice SAT’s and ACT’s for free online every Saturday through 5/30/20, to help students with their SAT and ACT test prep. This free resource is an easy-to-use, digital online test that has a proctored video with instructions, and live tech support is available. Read more >>
22
Apr
Hoth Therapeutics Announces Top Line Preclinical Data from Cutaneous Lupus Erythematosus (CLE) Study
Hoth Therapeutics, Inc., a biopharmaceutical company, today announced top line data from its Cutaneous Lupus Erythematosus (CLE) study, a chronic autoimmune skin disease, in partnership with Zylö Therapeutics, Inc. for topical administration of Anandamide (AEA)-loaded Z-pods™. Read more >>
22
Apr
eSight launches remote benefit for visually impaired employees
Vision enhancement platform eSight has launched a program that allows employees who are visually impaired to become productive in a non-touch, socially responsible way to address needs during the coronavirus crisis. Read more >>
21
Apr
COVID-19 Response Fund supports innovation solutions during pandemic
The Dartmouth General Hospital Foundation is raising money for a COVID-19 Response Fund to support the needs of staff and patients during the pandemic. According to Dr. Kevin Spencer, an emergency department physician at the Dartmouth General Hospital and mechanical engineer, the COVID-19 Response Fund is focused on three specific areas…His team has joined forces with Spring Loaded Technology, an organization that develops and manufactures novel assistive devices that reduce pain and restore mobility, to produce face shields. Read […]